Epidemiology of Venous Thromboembolism After Second Cancer

References

• Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;122(10):1712–1723. doi:10.1182/blood-2013-04-46012123908465
   PubMed Web of Science ®Google Scholar
• Parpia S, Julian JA, Thabane L, Lee AY, Rickles FR, Levine MN. Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism. Contemp Clin Trials. 2011;32(6):829–833. doi:10.1016/j.cct.2011.07.00521777700
   PubMed Web of Science ®Google Scholar
• Sørensen HT, Mellemkjær L, Olsen J, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343(25):1846–1850. doi:10.1056/NEJM20001221343250411117976
   PubMed Web of Science ®Google Scholar
• Noble S, Prout H, Nelson A. Patients’ Experiences of LIving with CANcer-associated thrombosis: the PELICAN study. Patient Prefer Adherence. 2015;9:337–345. doi:10.2147/PPA.S7937325750522
   PubMed Web of Science ®Google Scholar
• Farge D, Cajfinger F, Falvo N, et al. Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC). Oncotarget. 2018;9(43):26990–26999. doi:10.18632/oncotarget.2545429930745
   PubMedGoogle Scholar
• De AR, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol. 2014;15(1):23–34.24314615
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet (London, England). 2018;391(10125):1023–1075. doi:10.1016/S0140-6736(17)33326-3
   PubMed Web of Science ®Google Scholar
• Van HM, Adolfsson J, Garmo H, et al. Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden. Lancet Oncol. 2010;11(5):450–458.20395174
   PubMed Web of Science ®Google Scholar
• Brand JS, Hedayati E, Bhoo-Pathy N, et al. Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: a population-based cohort study. Cancer. 2017;123:468–47527727456
   PubMed Web of Science ®Google Scholar
• Walker AJ, West J, Card TR, Crooks C, Kirwan CC, Grainge MJ. When are breast cancer patients at highest risk of venous thromboembolism: a cohort study using English healthcare data. Blood. 2015.
   Google Scholar
• Walker AJ, West J, Card TR, Humes DJ, Grainge MJ. Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from England. J Thromb Haemost. 2014;12(5):641–649. doi:10.1111/jth.1253324977288
   PubMed Web of Science ®Google Scholar
• Gade IL, Brækkan SK, Næss IA, et al. Long-term incidence of venous thromboembolism in cancer: the Scandinavian thrombosis and cancer cohort. Th Open. 2018;02(02):e131–e138. doi:10.1055/s-0038-1641678
   Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S9112526604824
   PubMed Web of Science ®Google Scholar
• Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39(7_suppl):22–25. doi:10.1177/140349481038796521775345
   PubMed Web of Science ®Google Scholar
• Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry–history, content, quality and use. Dan Med Bull. 1997;44(5):535–539.9408738
   PubMed Web of Science ®Google Scholar
• Nordic Centre for Classifications in Health Care. NOMESCO Classification of Surgical Procedures. Oslo; 2010 Available from: https://norden.diva-portal.org/smash/get/diva2:970547/FULLTEXT01.pdf. Accessed March 30, 2019.
   Google Scholar
• Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263–268.10421985
   PubMed Web of Science ®Google Scholar
• The Danish National Heatlh Authority (Sundhedsstyrrelsen). Det Moderne Cancerregister - Metode Og Kvalitet [The modern cancer register - methods and quality]. Copenhagen; 2009 Available from: https://sundhedsdatastyrelsen.dk/da/registre-og-services/om-de-nationale-sundhedsregistre/sygedomme-laegemidler-og-behandlinger/cancerregisteret. Accessed March 30, 2019 Danish.
   Google Scholar
• Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902–4907. doi:10.1182/blood-2007-10-11632718216292
   PubMed Web of Science ®Google Scholar
• Pabinger I, van Es N, Heinze G, et al. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. Lancet Haematol. 2018;5(7):e289. doi:10.1016/S2352-3026(18)30063-229885940
   PubMed Web of Science ®Google Scholar
• Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tjonneland A, Johnsen SP. Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol. 2010;63(2):223–228. doi:10.1016/j.jclinepi.2009.03.01819595569
   PubMed Web of Science ®Google Scholar
• Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7):38–41. doi:10.1177/140349481039471721775349
   PubMed Web of Science ®Google Scholar
• Kearon C, Ageno W, Cannegieter SC, et al. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost. 2016;14(7):1480–1483. doi:10.1111/jth.1333627428935
   PubMed Web of Science ®Google Scholar
• Cohen A, Katholing A, Rietbrock S, Bamber L, Martinez C. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study. Thromb Haemost. 2017;117(1):57–65. doi:10.1160/TH15-08-068627709226
   PubMed Web of Science ®Google Scholar
• Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. Eur J Cancer. 2013;49(6):1404–1413. doi:10.1016/j.ejca.2012.10.02123146958
   PubMed Web of Science ®Google Scholar
• Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med. 2012;9(7):e1001275. doi:10.1371/journal.pmed.100127522859911
   PubMed Web of Science ®Google Scholar
• Cronin-Fenton D, Sondergaard F, Pedersen LA, et al. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006. Br J Cancer. 2010;103(7):947–953. doi:10.1038/sj.bjc.660588320842120
   PubMed Web of Science ®Google Scholar
• Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006;166(4):458–464. doi:10.1001/archinte.166.4.45816505267
   PubMed Web of Science ®Google Scholar
• Martinez C, Cohen AT, Bamber L, Rietbrock S. Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer. Thromb Haemost. 2014;112(2):255–263. doi:10.1160/TH13-09-079324695909
   PubMed Web of Science ®Google Scholar
• Blix K, Gran OV, Severinsen MT, et al. Impact of time since diagnosis and mortality rate on cancer‐associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort. J Thromb Haemost. 2018;16(7):1327–1355. doi:10.1111/jth.1413029691978
   PubMed Web of Science ®Google Scholar
• Heit JA, Lahr BD, Ashrani AA, Petterson TM, Bailey KR. Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study. Thromb Res. 2015;136(2):298–307. doi:10.1016/j.thromres.2015.06.03026143712
   PubMed Web of Science ®Google Scholar
• Chee CE, Ashrani AA, Marks RS, et al. Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood. 2014;123(25):3972–3978. doi:10.1182/blood-2014-01-54973324782507
   PubMed Web of Science ®Google Scholar
• Samama CM, Afshari A, Force EVGT. European guidelines on perioperative venous thromboembolism prophylaxis. Eur J Anaesthesiol. 2017;35(2):1.
   Web of Science ®Google Scholar
• Gould M, Garcia D, Wren S, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e227S–e277S. doi:10.1378/chest.11-229722315263
   PubMed Web of Science ®Google Scholar
• Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98(4):756–764. doi:10.1160/TH07-03-021217938798
   PubMed Web of Science ®Google Scholar
• Stubbs JM, Assareh H, Curnow J, Hitos K, Achat HM. Incidence of in-hospital and post-discharge diagnosed hospital-associated venous thromboembolism using linked administrative data. Intern Med J. 2018;48:157–165.29139173
   PubMed Web of Science ®Google Scholar
• Lyman GH, Bohlke K, Khorana AA, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014. J Clin Oncol. 2015;33(6):654–656. doi:10.1200/JCO.2014.59.735125605844
   PubMed Web of Science ®Google Scholar
• Mandala M, Falanga A, Roila F, Group EGW. Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22(Suppl 6):vi85–vi92. doi:10.1093/annonc/mdr39221908511
   PubMed Web of Science ®Google Scholar
• Watson HG, Keeling DM, Laffan M, Tait RC, Makris M; for Standards in Haematology BC. Guideline on aspects of cancer-related venous thrombosis. Br J Haematol. 2015;170(5):640–648. doi:10.1111/bjh.1355626114207
   PubMed Web of Science ®Google Scholar
• Gade IL, Riddersholm SJ, Christiansen I, et al. Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study. Blood Adv. 2018;2(21):3025–3034. doi:10.1182/bloodadvances.201802389530425066
   PubMed Web of Science ®Google Scholar